INDBInternet News Database 2.5 Updated just now · 414 sources Show or hide images Light or dark

Why India rejected a patent application for shorter drug-resistant TB treatment

1 source1 article First seen Updated India Truth score 43

Save Compare coverage
Image from The Hindu

Summary

The decision could open the door to greater generic competition, but its impact on treatment costs will depend on drug availability, pricing, and access to care

Description from The Hindu.

Who is covering this

  1. The Hindu Leans left Factuality: High IN
    Why India rejected a patent application for shorter drug-resistant TB treatment | Explained

    The decision could open the door to greater generic competition, but its impact on treatment costs will depend on drug availability, pricing, and access to care